Overall rank by patents
#6,242
of 50,000 tracked assignees
USPTO PatentsView assignee record - 54 granted patents across 23 technology areas, recorded in grant years 2015–2024. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61M (DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY ; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY ; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR).
The verdict
According to USPTO PatentsView, Gerresheimer ranks #6,242 of 50,000 tracked US assignees by granted-patent volume, with 54 patents across 23 technology areas.
USPTO PatentsView assignee plate
Corpus R6242 · Foreign Corporation #6,242 · 54 grants
GRANTS-SMALL · UPPER-Q · PHOTO-FINISH · CPC-FOCUS · INNOV-PAR · CLAIMS-RICH · TYPE-FRNCORP · VEL-FLAT · BOOK-FULL
Nearest grant-volume peer: Entefy Inc. (±0 grants)
Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.
Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.
Qualcomm Incorporated · highest
85 score
Allnex Netherlands BV · near
42 score
Cydex Pharmaceuticals · near
42 score
Gerresheimer Regensb… · this assignee
42 score
Heraeus Precious Met… · near
42 score
San Diego Gas & Elec… · near
42 score
3D Lighting Innovati… · lowest
7 score
What this shows Gerresheimer Regensburg Gmbh stamps GRANTS-SMALL, UPPER-Q, PHOTO-FINISH, CPC-FOCUS, INNOV-PAR, CLAIMS-RICH, TYPE-FRNCORP, VEL-FLAT, BOOK-FULL. Volume places it #6,242 of 50,000; Innovation Score 42.2/100 sits in the top 31% of the PatentsView-derived corpus. Closest grant-volume peer on this plate is Entefy Inc. (±0 grants).
Gerresheimer Regensburg Gmbh has been granted 54 US utility patents between 2015 and 2024, placing Gerresheimer Regensburg Gmbh at #6,242 of 50,000 across all assignees tracked by PlainPatent. This portfolio spans 23 distinct Cooperative Patent Classification (CPC) subclasses, averaging 12.4 claims per patent with primary concentration in A61M (DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY ; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY ; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR). As a Foreign Corporation, Gerresheimer Regensburg Gmbh is one of the more focused assignees in the PatentsView dataset. By volume, Gerresheimer sits between Expro North SEA Limited (54 patents, rank #6,237) and Hermes Sellier (societe Par Actions Simplifiee) (54 patents, rank #6,245) - the closest US assignees by grant volume. The composite Innovation Score of 42.2/100 blends portfolio volume, grant velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.
Grant cadence records the difference between two grant-year windows. Between 2020 and 2024 the company received 28 grants, compared with 26 in the 2015–2019 window, a +8% shift in five-year grant velocity. Both windows cover five complete grant years; the latest PatentsView year is a partial release and is excluded from this comparison, though it still appears in the yearly table and chart below. Grant timing can lag the related application by years, so this comparison does not establish current R&D spending, strategic intent, or a company’s application activity. The Foreign Corporation classification provides context for the assignee record, not a conclusion about its business strategy.
Claim depth and technology breadth describe this aggregate record. Gerresheimer Regensburg Gmbh's 12.4 average claims per patent is an average count, not a measure of claim scope, legal strength, enforceability, or design-around risk. The record spans 23 CPC subclasses. Combined with portfolio volume, these figures let readers compare the documented grant records of assignees in similar technology classes.
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
EXPRO NORTH SEA LIMITED
54 patents
Entefy Inc.
54 patents
Facense Ltd.
54 patents
Frore Systems Inc.
54 patents
Gift Card Impressions, LLC
54 patents
HINDUSTAN PETROLEUM CORPORATION LIMITED
54 patents
HLI SOLUTIONS, INC.
54 patents
Hermes Sellier (Societe Par Actions Simplifiee)
54 patents
Gerresheimer Regensburg GmbH
54 patents
What this shows Gerresheimer holds 54 patents at rank #6,241, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
By rank, the assignees closest to #6,241 in granted patent volume.
Other assignees with the most granted patents in Gerresheimer's primary technology class.
Two PlainPatent-derived peer sets for Gerresheimer, neither rank-band nor same-CPC leaders (those blocks stay above).
Nearest assignees by Innovation Score (42 here).
Nearest assignees by average claims per patent (12.4 here).
Gerresheimer's Innovation Score vs. every tracked assignee
Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)
42 Top 31% higher than 69% of 50,000 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2015 | 2 | 3.7% |
| 2016 | 3 | 5.6% |
| 2017 | 6 | 11.1% |
| 2018 | 8 | 14.8% |
| 2019 | 7 | 13.0% |
| 2020 | 11 | 20.4% |
| 2021 | 4 | 7.4% |
| 2022 | 3 | 5.6% |
| 2023 | 9 | 16.7% |
| 2024 | 1 | 1.9% |
Top 15 of 23 technology areas
Overall rank by patents
#6,242
of 50,000 tracked assignees
42.2 out of 100
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.